Treatment Considerations for Managing a Patient With Congenital Plasminogen Deficiency Who Becomes Pregnant

Conference|ASH Annual Meeting and Exposition - American Society of Hematology Annual Meeting and Exposition

Per Morten Sandset, MD, of the University of Oslo and Oslo University Hospital, discusses the treatment considerations necessary to properly manage a patient with congenital plasminogen deficiency after she became pregnant.

Pharmacy Times^® interviewed Per Morten Sandset, MD, a principal investigator and professor in the Department of Haematology and the Research Institute of Internal Medicine at the University of Oslo and Oslo University Hospital, on his presentation at the 62^nd ASH Annual Meeting and Exposition. The presentation discusses research conducted to investigate the successful pregnancy of a patient with infertility due to congenital plasminogen deficiency who was treated with intravenous plasminogen replacement therapy.

In this video, Sandset discusses the treatment considerations necessary to properly manage this patient with congenital plasminogen deficiency after she became pregnant.